Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/06/19
End: 03/19/21
Due: 03/19/22
Phase: N/A
Priority: Normal
Start: 06/13/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 09/08/21
End: 10/31/24
Due: 10/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence | NCT04102553 | ABX advanced biochemical compounds GmbH | user2@example.com | None | 2019-03-06 | 2021-03-19 | 2022-03-19 | - | - | 2025-07-14 |
| Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer | NCT06122584 | ABX advanced biochemical compounds GmbH | user2@example.com | None | 2024-06-13 | 2025-04-30 | 2026-04-30 | - | - | 2025-07-14 |
| Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer | NCT04742361 | ABX advanced biochemical compounds GmbH | user2@example.com | None | 2021-09-08 | 2024-10-31 | 2025-10-31 | - | - | 2025-07-14 |